MAUNA KEA TECHNOLOGIES (ALMKT.PA) Stock Fundamental Analysis

EPA:ALMKT • FR0010609263

0.1764 EUR
+0.01 (+3.64%)
Last: Feb 26, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ALMKT. ALMKT was compared to 65 industry peers in the Health Care Equipment & Supplies industry. ALMKT has a bad profitability rating. Also its financial health evaluation is rather negative. ALMKT has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • ALMKT had negative earnings in the past year.
  • ALMKT had a negative operating cash flow in the past year.
  • ALMKT had negative earnings in each of the past 5 years.
  • In the past 5 years ALMKT always reported negative operating cash flow.
ALMKT.PA Yearly Net Income VS EBIT VS OCF VS FCFALMKT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M

1.2 Ratios

  • The Return On Assets of ALMKT (-82.18%) is worse than 90.77% of its industry peers.
Industry RankSector Rank
ROA -82.18%
ROE N/A
ROIC N/A
ROA(3y)-45.6%
ROA(5y)-50.64%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALMKT.PA Yearly ROA, ROE, ROICALMKT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

1.3 Margins

  • ALMKT has a Gross Margin of 31.67%. This is amonst the worse of the industry: ALMKT underperforms 81.54% of its industry peers.
  • ALMKT's Gross Margin has improved in the last couple of years.
  • ALMKT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y39.93%
GM growth 5YN/A
ALMKT.PA Yearly Profit, Operating, Gross MarginsALMKT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. Health

2.1 Basic Checks

  • ALMKT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for ALMKT has been increased compared to 1 year ago.
  • ALMKT has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, ALMKT has a worse debt to assets ratio.
ALMKT.PA Yearly Shares OutstandingALMKT.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ALMKT.PA Yearly Total Debt VS Total AssetsALMKT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • ALMKT has an Altman-Z score of -7.63. This is a bad value and indicates that ALMKT is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -7.63, ALMKT is not doing good in the industry: 89.23% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -7.63
ROIC/WACCN/A
WACC7.12%
ALMKT.PA Yearly LT Debt VS Equity VS FCFALMKT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

  • A Current Ratio of 0.23 indicates that ALMKT may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.23, ALMKT is doing worse than 92.31% of the companies in the same industry.
  • ALMKT has a Quick Ratio of 0.23. This is a bad value and indicates that ALMKT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ALMKT has a Quick ratio of 0.12. This is amonst the worse of the industry: ALMKT underperforms 95.38% of its industry peers.
Industry RankSector Rank
Current Ratio 0.23
Quick Ratio 0.12
ALMKT.PA Yearly Current Assets VS Current LiabilitesALMKT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • ALMKT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -114.81%.
  • Looking at the last year, ALMKT shows a very negative growth in Revenue. The Revenue has decreased by -26.96% in the last year.
  • Measured over the past years, ALMKT shows a small growth in Revenue. The Revenue has been growing by 0.60% on average per year.
EPS 1Y (TTM)-114.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.27%
Revenue 1Y (TTM)-26.96%
Revenue growth 3Y-0.2%
Revenue growth 5Y0.6%
Sales Q2Q%-4.62%

3.2 Future

  • The Earnings Per Share is expected to grow by 23.86% on average over the next years. This is a very strong growth
  • ALMKT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.29% yearly.
EPS Next Y50%
EPS Next 2Y74.64%
EPS Next 3Y23.86%
EPS Next 5YN/A
Revenue Next Year0%
Revenue Next 2Y19.76%
Revenue Next 3Y19.29%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALMKT.PA Yearly Revenue VS EstimatesALMKT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2M 4M 6M 8M 10M
ALMKT.PA Yearly EPS VS EstimatesALMKT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.2 -0.4 -0.6 -0.8

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ALMKT. In the last year negative earnings were reported.
  • The Price/Forward Earnings ratio is 1.63, which indicates a rather cheap valuation of ALMKT.
  • Based on the Price/Forward Earnings ratio, ALMKT is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • ALMKT is valuated cheaply when we compare the Price/Forward Earnings ratio to 28.13, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 1.63
ALMKT.PA Price Earnings VS Forward Price EarningsALMKT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALMKT.PA Per share dataALMKT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1 -0.1 -0.15

4.3 Compensation for Growth

  • ALMKT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as ALMKT's earnings are expected to grow with 23.86% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y74.64%
EPS Next 3Y23.86%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ALMKT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MAUNA KEA TECHNOLOGIES

EPA:ALMKT (2/26/2026, 7:00:00 PM)

0.1764

+0.01 (+3.64%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-02
Earnings (Next)04-09
Inst Owners6.18%
Inst Owner ChangeN/A
Ins Owners0.36%
Ins Owner ChangeN/A
Market Cap30.86M
Revenue(TTM)7.66M
Net Income(TTM)-10.40M
Analysts86.67
Price Target0.51 (189.12%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-400%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-24.75%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1.63
P/S 4.03
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.16
EYN/A
EPS(NY)0.11
Fwd EY61.31%
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0.04
BVpS-0.17
TBVpS-0.18
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -82.18%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.67%
FCFM N/A
ROA(3y)-45.6%
ROA(5y)-50.64%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y39.93%
GM growth 5YN/A
F-Score3
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 12.33%
Cap/Sales 3.08%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.23
Quick Ratio 0.12
Altman-Z -7.63
F-Score3
WACC7.12%
ROIC/WACCN/A
Cap/Depr(3y)16.65%
Cap/Depr(5y)36.4%
Cap/Sales(3y)2.78%
Cap/Sales(5y)7.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-114.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.27%
EPS Next Y50%
EPS Next 2Y74.64%
EPS Next 3Y23.86%
EPS Next 5YN/A
Revenue 1Y (TTM)-26.96%
Revenue growth 3Y-0.2%
Revenue growth 5Y0.6%
Sales Q2Q%-4.62%
Revenue Next Year0%
Revenue Next 2Y19.76%
Revenue Next 3Y19.29%
Revenue Next 5YN/A
EBIT growth 1Y-594.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year7.14%
EBIT Next 3Y27.11%
EBIT Next 5YN/A
FCF growth 1Y-3920%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2465%
OCF growth 3YN/A
OCF growth 5YN/A

MAUNA KEA TECHNOLOGIES / ALMKT.PA FAQ

What is the ChartMill fundamental rating of MAUNA KEA TECHNOLOGIES (ALMKT.PA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALMKT.PA.


What is the valuation status of MAUNA KEA TECHNOLOGIES (ALMKT.PA) stock?

ChartMill assigns a valuation rating of 4 / 10 to MAUNA KEA TECHNOLOGIES (ALMKT.PA). This can be considered as Fairly Valued.


How profitable is MAUNA KEA TECHNOLOGIES (ALMKT.PA) stock?

MAUNA KEA TECHNOLOGIES (ALMKT.PA) has a profitability rating of 1 / 10.


What is the financial health of MAUNA KEA TECHNOLOGIES (ALMKT.PA) stock?

The financial health rating of MAUNA KEA TECHNOLOGIES (ALMKT.PA) is 0 / 10.